Stock A310210 VORONOI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Voronoi, Inc.

Equities

A310210

KR7310210000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
46,300 KRW +8.56% Intraday chart for Voronoi, Inc. -5.22% -14.26%
2023 Voronoi, Inc.(KOSDAQ:A310210) added to S&P Global BMI Index CI
2023 Voronoi to Raise 45 Billion Won From Shares Issuance; Shares Jump 9% MT

Business Summary

Voronoi Inc is a Korea-based company principally engaged in the research and development of new drug candidates. The Company is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The Company is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.

Number of employees: 77

Managers

Managers TitleAgeSince
Dae-Kwon Kim CEO
 Chief Executive Officer 47 -
Hyun-Tae Kim CEO
 Chief Executive Officer 47 -
Sang-Jin Woo DFI
 Director of Finance/CFO 48 -
Ikhwan Sung COO
 Chief Operating Officer - 18-10-31
Sung-Hwan Kim BRD
 Director/Board Member 48 -
Sun-Ho Kim AUD
 Comptroller/Controller/Auditor 44 -

Members of the board

Members of the board TitleAgeSince
Seok-Gyoon Yoon BRD
 Director/Board Member 66 -
Gwang-Bok Heo BRD
 Director/Board Member 54 -
Hyun-Tae Kim CEO
 Chief Executive Officer 47 -
Dae-Kwon Kim CEO
 Chief Executive Officer 47 -
Sang-Jin Woo DFI
 Director of Finance/CFO 48 -
Sung-Hwan Kim BRD
 Director/Board Member 48 -
Sang-Wook Lee BRD
 Director/Board Member 47 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,780,225 10,284,443 ( 57.84 %) 403,401 ( 2.269 %) 57.84 %

Shareholders

NameEquities%Valuation
Hyun-Tae Kim
37.30 %
6,632,019 37.30 % 199 M ₩
Dok-soo Jang
3.434 %
610,602 3.434 % 18 M ₩
VORONOI, INC.
2.269 %
403,401 2.269 % 12 M ₩
Hyun-seok Kim
1.350 %
240,000 1.350 % 7 M ₩
Hwan-geun Choi
1.049 %
186,552 1.049 % 6 M ₩
Dae-yun Kim
0.9989 %
177,600 0.9989 % 5 M ₩
Nam-du Kim
0.7767 %
138,104 0.7767 % 4 M ₩
Jae Young Ahn
0.1524 %
27,096 0.1524 % 812 166 ₩
Dae-Kwon Kim
0.1345 %
23,923 0.1345 % 717 059 ₩
Sang-Jin Woo
0.0771 %
13,700 0.0771 % 410 639 ₩

Holdings

NameEquities%Valuation
VORONOI, INC.
2.27%
 403,401 2.27% 12,091,396 $

Company contact information

Voronoi, Inc.

18th Floor S-dong 32 Songdogwahak-ro

21984, Inchon

+

http://www.voronoi.io
address Voronoi, Inc.(A310210)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
46,550 KRW
Average target price
80,000 KRW
Spread / Average Target
+71.86%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
VORONOI, INC. Stock Voronoi, Inc.
-14.26% 582M
MODERNA, INC. Stock Moderna, Inc.
+36.74% 51.07B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-7.86% 38.78B
LONZA GROUP AG Stock Lonza Group AG
+35.31% 38.61B
CELLTRION, INC. Stock Celltrion, Inc.
-8.98% 27.32B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.09% 26.35B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-18.97% 19.46B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+40.90% 13.58B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.48% 12.46B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.04% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A310210 Stock
  4. Company Voronoi, Inc.